{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:04:51Z","timestamp":1792631091430,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"vor","delay-in-days":714,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007375","name":"Universidade Federal de Minas Gerais Pro-Reitoria de Pesquisa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007375","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.bmc.2021.116467","type":"journal-article","created":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T03:46:47Z","timestamp":1634010407000},"page":"116467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["In vitro activity of N-phenyl-1,10-phenanthroline-2-amines against tachyzoites and bradyzoites of Toxoplasma gondii"],"prefix":"10.1016","volume":"50","author":[{"given":"Erica S.","family":"Martins-Duarte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana de Araujo","family":"Portes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon Borges","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo Silva","family":"Pires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Garden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanderley","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2021.116467_b0005","doi-asserted-by":"crossref","unstructured":"Aleixo ALQ do C, Curi ALL, Benchimol EI, Amendoeira MRR. Toxoplasmic retinochoroiditis: clinical characteristics and visual outcome in a prospective study. PLoS Negl Trop Dis 2016;10(5). doi:10.1371\/journal.pntd.0004685.","DOI":"10.1371\/journal.pntd.0004685"},{"issue":"6","key":"10.1016\/j.bmc.2021.116467_b0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153921","article-title":"Time to HAART initiation after diagnosis and treatment of opportunistic infections in patients with AIDS in Latin America","volume":"11","author":"Crabtree-Ram\u00edrez","year":"2016","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.bmc.2021.116467_b0015","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.05013-11","article-title":"Epidemiology of and diagnostic strategies for toxoplasmosis","volume":"25","author":"Robert-Gangneux","year":"2012","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/j.bmc.2021.116467_b0020","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/cid\/ciu793","article-title":"Ocular toxoplasmosis in the United States: Recent and remote infections","volume":"60","author":"Jones","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.bmc.2021.116467_b0025","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1007\/s00436-021-07282-w","article-title":"Toxoplasma gondii in South America: a differentiated pattern of spread, population structure and clinical manifestations","volume":"120","author":"de Lima","year":"2021","journal-title":"Parasitol Res"},{"issue":"4","key":"10.1016\/j.bmc.2021.116467_b0030","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00057-17","article-title":"Treatment of toxoplasmosis: Historical perspective, animal models, and current clinical practice","volume":"31","author":"Dunay","year":"2018","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10.1016\/j.bmc.2021.116467_b0035","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s40268-017-0206-8","article-title":"Adverse event profile of pyrimethamine-based therapy in toxoplasmosis: a systematic review","volume":"17","author":"Ben-Harari","year":"2017","journal-title":"Drugs R D"},{"issue":"3","key":"10.1016\/j.bmc.2021.116467_b0040","first-page":"132","article-title":"Sulfonamide allergies","volume":"7","author":"Giles","year":"2019","journal-title":"Pharm (Basel, Switzerland)"},{"issue":"2","key":"10.1016\/j.bmc.2021.116467_b0045","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/clinids\/22.2.268","article-title":"Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS","volume":"22","author":"Katlama","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.bmc.2021.116467_b0050","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.clinthera.2008.10.021","article-title":"Adverse drug reactions to treatments for ocular toxoplasmosis: A retrospective chart review","volume":"30","author":"Iaccheri","year":"2008","journal-title":"Clin Ther"},{"issue":"6","key":"10.1016\/j.bmc.2021.116467_b0055","article-title":"Trends in AIDS-defining opportunistic illnesses incidence over 25 years in Rio de Janeiro","volume":"9","author":"Coelho","year":"2014","journal-title":"Brazil PLoS One"},{"issue":"2","key":"10.1016\/j.bmc.2021.116467_b0060","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02164-19","article-title":"Latent toxoplasmosis effects on rodents and humans: How much is real and how much is media hype?","volume":"11","author":"Johnson","year":"2020","journal-title":"MBio"},{"key":"10.1016\/j.bmc.2021.116467_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2019.01012","article-title":"Negative effects of latent toxoplasmosis on mental health","volume":"10","author":"Flegr","year":"2020","journal-title":"Front Psychiatry"},{"issue":"4","key":"10.1016\/j.bmc.2021.116467_b0070","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1039\/C6OB02508K","article-title":"Copper(II) catalyzed synthesis of novel helical luminescent benzo[4,5]imidazo[1,2-a][1,10]phenanthrolines via an intramolecular C-H amination reaction","volume":"15","author":"da Silva","year":"2017","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmc.2021.116467_b0075","doi-asserted-by":"crossref","unstructured":"Day TA, Chen G-Z. The metalloprotease inhibitor 1,10-phenanthroline affects Schistosoma mansoni motor activity, egg laying and viability. Parasitology. 1998;116(4):319-325. doi:10.1017\/S0031182097002370.","DOI":"10.1017\/S0031182097002370"},{"key":"10.1016\/j.bmc.2021.116467_b0080","doi-asserted-by":"crossref","unstructured":"L.S. Santos ALS, L. Sodre C, S. Valle R, et al. Antimicrobial Action of Chelating Agents: Repercussions on the Microorganism Development, Virulence and Pathogenesis. Curr Med Chem. 2012;19(17):2715-2737. doi:10.2174\/092986712800609788.","DOI":"10.2174\/092986712800609788"},{"key":"10.1016\/j.bmc.2021.116467_b0085","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cbpa.2021.01.016","article-title":"Biological activities of polypyridyl-type ligands: implications for bioinorganic chemistry and light-activated metal complexes","volume":"61","author":"Hachey","year":"2021","journal-title":"Curr Opin Chem Biol"},{"issue":"19","key":"10.1016\/j.bmc.2021.116467_b0090","doi-asserted-by":"crossref","first-page":"14346","DOI":"10.1074\/jbc.275.19.14346","article-title":"The toxoplasma adhesive protein MIC2 is proteolytically processed at multiple sites by two parasite-derived proteases","volume":"275","author":"Carruthers","year":"2000","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.bmc.2021.116467_b0095","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3347\/kjp.2003.41.3.165","article-title":"Protease activity of 80 kDa protein secreted from the apicomplexan parasite Toxoplasma gondii","volume":"41","author":"Song","year":"2003","journal-title":"Korean J Parasitol"},{"issue":"1","key":"10.1016\/j.bmc.2021.116467_b0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.micinf.2015.09.016","article-title":"Development of dual fluorescent stage specific reporter strain of Toxoplasma gondii to follow tachyzoite and bradyzoite development in vitro and in vivo","volume":"18","author":"Paredes-Santos","year":"2016","journal-title":"Microbes Infect"},{"issue":"5","key":"10.1016\/j.bmc.2021.116467_b0105","article-title":"Synthesis and biological activity of novel zinc-itraconazole complexes in protozoan parasites and Sporothrix spp","volume":"64","author":"de Azevedo-Fran\u00e7a","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.bmc.2021.116467_b0110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.parint.2012.12.003","article-title":"Spontaneous cystogenesis in vitro of a Brazilian strain of Toxoplasma gondii","volume":"62","author":"Paredes-Santos","year":"2013","journal-title":"Parasitol Int"},{"key":"10.1016\/j.bmc.2021.116467_b0115","doi-asserted-by":"crossref","unstructured":"Cristina M Di, Dou Z, Lunghi M, et al. Toxoplasma depends on lysosomal consumption of autophagosomes for persistent infection. Nat Microbiol 2017 28. 2017;2(8):1-7. doi:10.1038\/nmicrobiol.2017.96.","DOI":"10.1038\/nmicrobiol.2017.96"},{"key":"10.1016\/j.bmc.2021.116467_b0120","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/978-1-4939-9857-9_15","article-title":"Toxoplasma gondii: Bradyzoite Differentiation in vitro and in vivo","volume":"2071","author":"Mayoral","year":"2020","journal-title":"Methods Mol Biol"},{"issue":"1\u20133","key":"10.1016\/j.bmc.2021.116467_b0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"10.1016\/j.bmc.2021.116467_b0130","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116467_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.parint.2021.102338","article-title":"In vitro study of the trypanocidal activity of anilinophenanthrolines against Trypanosoma cruzi","volume":"83","author":"Zuma","year":"2021","journal-title":"Parasitol Int"},{"issue":"3","key":"10.1016\/j.bmc.2021.116467_b0140","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.exppara.2012.12.011","article-title":"Toxoplasma gondii: The effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model","volume":"133","author":"Martins-Duarte","year":"2013","journal-title":"Exp Parasitol"},{"issue":"12","key":"10.1016\/j.bmc.2021.116467_b0145","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/j.1462-5822.2011.01681.x","article-title":"The organization of the wall filaments and characterization of the matrix structures of Toxoplasma gondii cyst form","volume":"13","author":"Lemgruber","year":"2011","journal-title":"Cell Microbiol"},{"issue":"9\u201310","key":"10.1016\/j.bmc.2021.116467_b0150","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.micinf.2017.12.003","article-title":"Observations on bradyzoite biology","volume":"20","author":"Tu","year":"2018","journal-title":"Microbes Infect"},{"issue":"3","key":"10.1016\/j.bmc.2021.116467_b0155","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0166-6851(86)90101-5","article-title":"Interferon-\u03b3 suppresses the growth of Toxoplasma gondii in human fibroblasts through starvation for tryptophan","volume":"20","author":"Pfefferkorn","year":"1986","journal-title":"Mol Biochem Parasitol"},{"issue":"4","key":"10.1016\/j.bmc.2021.116467_b0160","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1128\/EC.3.4.992-1003.2004","article-title":"Dynamics of Toxoplasma gondii differentiation","volume":"3","author":"Dzierszinski","year":"2004","journal-title":"Eukaryot Cell"},{"issue":"3","key":"10.1016\/j.bmc.2021.116467_b0165","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijpara.2003.12.001","article-title":"Toxoplasma gondii lacks the enzymes required for de novo arginine biosynthesis and arginine starvation triggers cyst formation","volume":"34","author":"Fox","year":"2004","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.bmc.2021.116467_b0170","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.608283","article-title":"A comparison of stage conversion in the coccidian apicomplexans Toxoplasma gondii, Hammondia hammondi, and Neospora caninum","volume":"10","author":"Sokol-Borrelli","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"issue":"11","key":"10.1016\/j.bmc.2021.116467_b0175","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/0020-7519(95)00066-B","article-title":"Interconnection between organellar functions, development and drug resistance in the protozoan parasite, Toxoplasma gondii","volume":"25","author":"Tomavo","year":"1995","journal-title":"Int J Parasitol"},{"issue":"1\u20132","key":"10.1016\/j.bmc.2021.116467_b0180","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.vetpar.2010.11.034","article-title":"Evaluation of three novel azasterols against Toxoplasma gondii","volume":"177","author":"Martins-Duarte","year":"2011","journal-title":"Vet Parasitol"},{"issue":"17","key":"10.1016\/j.bmc.2021.116467_b0185","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1242\/jcs.185223","article-title":"Apicoplast fatty acid synthesis is essential for pellicle formation at the end of cytokinesis in Toxoplasma gondii","volume":"129","author":"Martins-Duarte","year":"2016","journal-title":"J Cell Sci"},{"issue":"12","key":"10.1016\/j.bmc.2021.116467_b0190","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1007\/s00436-019-06493-6","article-title":"Development of an in vitro system to study the developmental stages of Toxoplasma gondii using a genetically modified strain expressing markers for tachyzoites and bradyzoites","volume":"118","author":"Portes","year":"2019","journal-title":"Parasitol Res"},{"key":"10.1016\/j.bmc.2021.116467_b0195","doi-asserted-by":"crossref","unstructured":"WJ S, V J. Mechanisms of Toxoplasma gondii persistence and latency. FEMS Microbiol Rev. 2012;36(3):717-733. doi:10.1111\/J.1574-6976.2011.00305.X.","DOI":"10.1111\/j.1574-6976.2011.00305.x"},{"key":"10.1016\/j.bmc.2021.116467_b0200","doi-asserted-by":"crossref","unstructured":"McPhillie M, Zhou Y, Bissati K El, et al. New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections. Sci Rep 2016 61. 2016;6(1):1-23. doi:10.1038\/srep29179.","DOI":"10.1038\/srep29179"},{"issue":"3","key":"10.1016\/j.bmc.2021.116467_b0205","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1051\/parasite\/1998053223","article-title":"Assessment of the activity of atovaquone-loaded nanocapsules in the treatment of acute and chronic murine toxoplasmosis","volume":"5","author":"Sordet","year":"1998","journal-title":"Parasite"},{"issue":"4","key":"10.1016\/j.bmc.2021.116467_b0210","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1128\/AAC.01203-07","article-title":"In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone","volume":"52","author":"Meneceur","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.bmc.2021.116467_b0215","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1128\/AAC.36.2.326","article-title":"In vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against the cyst form of Toxoplasma gondii","volume":"36","author":"Araujo","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.bmc.2021.116467_b0220","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1128\/AAC.35.2.293","article-title":"Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii","volume":"35","author":"Araujo","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2021.116467_b0225","unstructured":"Ferguson DJ, Huskinson-Mark J, Araujo FG, Remington JS. An ultrastructural study of the effect of treatment with atovaquone in brains of mice chronically infected with the ME49 strain of Toxoplasma gondii. Int J Exp Pathol. 1994;75(2):111. Accessed July 10, 2021. \/pmc\/articles\/PMC2002108\/?report=abstract."},{"issue":"8","key":"10.1016\/j.bmc.2021.116467_b0230","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/00325481.2019.1655258","article-title":"Perspective on current and emerging drugs in the treatment of acute and chronic toxoplasmosis","volume":"131","author":"Lapinskas","year":"2019","journal-title":"Postgrad Med"},{"key":"10.1016\/j.bmc.2021.116467_b0235","doi-asserted-by":"crossref","unstructured":"McCann M, Kellett A, Kavanagh K, Devereux M, L.S. Santos A. Deciphering the Antimicrobial Activity of Phenanthroline Chelators. Curr Med Chem. 2012;19(17):2703-2714. doi:10.2174\/092986712800609733.","DOI":"10.2174\/092986712800609733"},{"issue":"11","key":"10.1016\/j.bmc.2021.116467_b0240","doi-asserted-by":"crossref","first-page":"8802","DOI":"10.1074\/jbc.M109072200","article-title":"Extracellular release of the glycosylphosphatidylinositol (GPI)-linked Leishmania surface metalloprotease, gp63, is independent of GPI phospholipolysis. Implications for parasite virulence","volume":"277","author":"McGwire","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2021.116467_b0245","doi-asserted-by":"crossref","unstructured":"Saini S, Bharati K, Shaha C, Mukhopadhyay CK. Zinc depletion promotes apoptosis-like death in drug-sensitive and antimony-resistance Leishmania donovani. Sci Rep 2017 71. 2017;7(1):1-14. doi:10.1038\/s41598-017-10041-6.","DOI":"10.1038\/s41598-017-10041-6"},{"issue":"10","key":"10.1016\/j.bmc.2021.116467_b0250","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1128\/AAC.00324-16","article-title":"Administration of zinc chelators improves survival of mice infected with Aspergillus fumigatus both in monotherapy and in combination with caspofungin","volume":"60","author":"Laskaris","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2021.116467_b0255","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev.nu.07.070187.001343","article-title":"Zinc in DNA replication and transcription","volume":"7","author":"Wu","year":"1987","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.bmc.2021.116467_b0260","doi-asserted-by":"crossref","unstructured":"MacDonald RS. The role of zinc in growth and cell proliferation. In: Journal of Nutrition. Vol 130. Oxford Academic; 2000:1500S-1508S. doi:10.1093\/jn\/130.5.1500s.","DOI":"10.1093\/jn\/130.5.1500S"},{"key":"10.1016\/j.bmc.2021.116467_b0265","doi-asserted-by":"crossref","unstructured":"Macleod RA. The toxicity of o-phenanthroline for lactic acid bacteria. J Biol Chem. 1952;197(2):751-761. doi:10.1016\/s0021-9258(18)55631-3.","DOI":"10.1016\/S0021-9258(18)55631-3"},{"issue":"2","key":"10.1016\/j.bmc.2021.116467_b0270","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/icb.1969.21","article-title":"The biological actions of 1,10-phenanthroline and 2,2\u2032-bipyridine hydrochlorides, quaternary salts and metal chelates and related compounds","volume":"47","author":"Dwyer","year":"1969","journal-title":"Aust J Exp Biol Med Sci"},{"issue":"6","key":"10.1016\/j.bmc.2021.116467_b0275","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0891-5849(92)90099-3","article-title":"Interactions of 1,10-phenanthroline and its copper complex with Ehrlich cells","volume":"12","author":"Byrnes","year":"1992","journal-title":"Free Radic Biol Med"},{"issue":"9","key":"10.1016\/j.bmc.2021.116467_b0280","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/cmdc.200800097","article-title":"Phenanthroline derivatives with improved selectivity as DNA-targeting anticancer or antimicrobial drugs","volume":"3","author":"Roy","year":"2008","journal-title":"ChemMedChem"},{"issue":"17\u201318","key":"10.1016\/j.bmc.2021.116467_b0285","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/j.ccr.2010.04.008","article-title":"1,10-Phenanthroline: A versatile building block for the construction of ligands for various purposes","volume":"254","author":"Bencini","year":"2010","journal-title":"Coord Chem Rev"},{"issue":"1\u20132","key":"10.1016\/j.bmc.2021.116467_b0290","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cbi.2006.08.025","article-title":"In vitro anti-tumour effect of 1,10-phenanthroline-5,6-dione (phendione), [Cu(phendione)3](ClO4)2\u00b74H2O and [Ag(phendione)2]ClO4 using human epithelial cell lines","volume":"164","author":"Deegan","year":"2006","journal-title":"Chem Biol Interact"},{"issue":"13","key":"10.1016\/j.bmc.2021.116467_b0295","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1021\/acs.inorgchem.0c00925","article-title":"Copper complexes with 1,10-phenanthroline derivatives: underlying factors affecting their cytotoxicity","volume":"59","author":"Nunes","year":"2020","journal-title":"Inorg Chem"},{"issue":"4","key":"10.1016\/j.bmc.2021.116467_b0300","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1021\/acs.bioconjchem.7b00781","article-title":"Human telomeric G-quadruplex selective fluoro-isoquinolines induce apoptosis in cancer cells","volume":"29","author":"Maiti","year":"2018","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.bmc.2021.116467_b0305","doi-asserted-by":"crossref","unstructured":"Tang D, Kang R, Berghe T Vanden, Vandenabeele P, Kroemer G. The molecular machinery of regulated cell death. Cell Res 2019 295. 2019;29(5):347-364. doi:10.1038\/s41422-019-0164-5.","DOI":"10.1038\/s41422-019-0164-5"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621004752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621004752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:15:36Z","timestamp":1760836536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089621004752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":61,"alternative-id":["S0968089621004752"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116467","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro activity of N-phenyl-1,10-phenanthroline-2-amines against tachyzoites and bradyzoites of Toxoplasma gondii","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116467","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116467"}}